In episode 70, Coffey talks with Matt Zemon about the workplace implications of the use of ketamine and other psychedelics.
They discuss the therapeutic use of ketamine; ongoing research on psychedelics’ effect on well being; what employers should understand about ketamine and other psychedelics; what ketamine therapy entails; and the future of psychedelics as therapeutic tools.
Good Morning, HR is brought to you by Imperative—premium background checks with fast and friendly service. For more information about our commitment to quality and excellent customer service, visit us at https://imperativeinfo.com.
Please take a moment to rate and review Good Morning, HR on Apple Podcasts!
This episode is pre-approved for .5 hour HR (General) recertification credit for HRCI-certified professionals and .5 professional development credit for SHRM-certified professionals. Slide down the page to claim your recertification credits!
Matt Zemon is the CEO and Co-Founder of HAPPŸŸ, a mental wellness company that specializes in psychedelic-assisted ketamine therapy along with digital therapeutics that promote life-transforming outcomes.
As an entrepreneur in the wellbeing sector, Matt was the co-founder and Chief Strategy Officer of Psychable, an online community connecting people who would like to explore the healing power of psychedelics with a network of practitioners and psychedelic-based treatments, and the co-founder of Take2Minutes, a nonprofit dedicated to helping individuals improve their mental health and wellbeing.
Prior to focusing on wellbeing, Matt had two other successful exits.
Matt is the author of Psychedelics for Everyone: A Beginner’s Guide to these Powerful Medicines for Anxiety, Depression, Addiction, PTSD, and Expanding Consciousness and received his Master of Science in Psychology and Neuroscience of Mental Health with honors from King’s College London.